Search for: "A AND L LABORATORIES INC" Results 401 - 420 of 523
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Oct 2011, 7:38 pm by Kiera Flynn
Petitioners’ reply Amicus brief of International Municipal Lawyers Association   Barr Laboratories, Inc. v. [read post]
30 Aug 2010, 6:20 pm
" Windsurfing Int'l, Inc. v. [read post]
28 May 2020, 5:29 am by Schachtman
Relying upon pre-2000 Ninth Circuit case law, decided before the statutory language of Rule 702 was adopted, the court found that: “expert evidence is inadmissible where the analysis is the result of a faulty methodology or theory as opposed to imperfect execution of laboratory techniques whose theoretical foundation is sufficiently accepted in the scientific community to pass muster under Daubert. [read post]
9 Nov 2010, 3:09 pm
On March 19, 2007, Barr Laboratories, Inc. and Barr Pharmaceuticals, Inc. [read post]
9 Jan 2009, 7:00 am
(IP Think Tank) IEEE patent scorecard for 2008 is out (Innovationpartners) (Peter Zura's 271 Patent Blog) Patent databases: 2008 in review (Patent Librarian's Notebook) New kind codes for republished PCT documents (Patent Librarian’s Notebook) The model changes at PatentFreedom; Matsushita is top troll target (IAM) Patent litigation, the ITC, and hardship in the chip industry (IP finance)   Global - Copyright Public domain day 2009 (Creative Commons), (Michael Geist)… [read post]
15 Dec 2019, 9:01 pm by News Desk
This location is adjacent to a drain where, in 2017, FDA isolated L. monocytogenes and L. innocua. [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution –… [read post]
11 Aug 2019, 11:01 pm by News Desk
FDA laboratory analyses of the environmental swabs found the presence of Listeria monocytogenes (L. monocytogenes), a human pathogen, in your facility. [read post]
8 Nov 2009, 7:44 pm
LLC v Garmin Int’l, Inc (Chicago Intellectual Property Law Blog) District Court E D Texas: Motion for summary judgment as to patent defendant’s defences and counterclaims granted in p [read post]
8 Nov 2009, 7:44 pm
(IP finance) Gospel, gold diggers and gum trees: How sampling litigation changes the tune (IP Osgoode)   Australia A mere collocation - Full Federal Court allows appeal against grant of interlocutory injunction preventing Smith & Nephew entering negative pressure wound therapy market: Smith & Nephew P/L v Wake Forest University Health Sciences (ipwars.com) The Vegemite/iSnack trade mark saga down under: Fiasco or triumph? [read post]
8 Nov 2009, 7:44 pm
LLC v Garmin Int'l, Inc (Chicago Intellectual Property Law Blog) District Court E D Texas: Motion for summary judgment as to patent defendant's defences and counterclaims granted in part; antitrust claims severed: Fiber Systems International v Applied Optical Systems (EDTexweblog.com) District Court E D Texas: Motion to compel denied - non-compliance with 'meet and confer' rule: Konami Digital Entertainment Co v Harmonix Music (EDTexweblog.com) BPAI used… [read post]
18 Jul 2010, 12:44 pm
The reasoning of these decisions varied at times, but the theme was consistent and widely understood that "a series of steps for conducting business could not be patented" (at pages 26-27 of his decision Justice Stevens cited several such cases including US Credit Sys Co v American Credit Indem Co (1893), Hotel Security Checking Co v Lorraine Co (1908), Loew's Drive-In Theatres, Inc v Park-In Theatres, Inc (1949)). [read post]
20 Jul 2011, 4:04 am by Marie Louise
: Supreme Court hearing Human Genome Sciences Inc v Eli Lilly and Company (IPKat) Nexium (Esomeprazole) – UK: EWHC: Ranbaxy wins declaration of non-infringement: Ranbaxy v AstraZeneca (IPKat) Olanzapine – Spain: Supreme Court hands down landmark judgment on doctrine of equivalents and TRIPS (Kluwer Patent Blog) OxyContin (Oxycodone) – US: Purdue files patent infringement suit against Sandoz in response to Para IV certification (Patent Docs) Prevacid (Lansoprazole) –… [read post]
6 Oct 2015, 11:37 am by Joe Consumer
Barry Cappello, managing partner of Cappello & Noël in Santa Barbara. [read post]